RecruitingNot ApplicableNCT06354595
Feasibility Study of Multidimensional Rehabilitation in the Metaverse
Sponsor
Qu Shen
Enrollment
10 participants
Start Date
Mar 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The investigators evaluated and optimized the Metaverse multi-dimensional rehabilitation platform based on the use of the Metaverse multi-dimensional rehabilitation platform by colorectal cancer survivors and their families, and finally launched the Metaverse multi-dimensional rehabilitation platform.
Eligibility
Min Age: 18 YearsMax Age: 65 Years
Inclusion Criteria1
- Patients undergoing adjuvant therapy after radical colorectal cancer resection; Age over 18 years old, under 65 years old, non-pregnant; Volunteering to participate in the research of this topic; Mobile phones are available
Exclusion Criteria1
- Patients with multiple cancers; Have special dietary needs.
Interventions
DEVICEMultidimensional Rehabilitation in the Metaverse
Using the multidimensional rehabilitation space in the metaverse, evaluate the platform after use.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06354595
Related Trials
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651383 locations
Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
NCT0729907113 locations
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
NCT0613184043 locations
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
NCT066633199 locations
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid Tumors
NCT071072308 locations